by John Conrad | Jul 19, 2024 | NewsBrief
In a strategic move to expand its specialty biopharmaceuticals portfolio, Meitheal Pharmaceuticals has acquired the North American rights to CONTEPO™ (fosfomycin for injection) from Nabriva Therapeutics. The announcement, made on July 18, 2024, marks a significant...
by John Conrad | Jul 8, 2024 | NewsBrief
SGS North America has announced a significant expansion of its biologics testing capabilities at its Lincolnshire Center of Excellence in Illinois. This move strengthens the company’s presence in the state and positions it to better serve the growing...
